If you’ve launched a pharmaceutical product to market, you know that navigating complex state and federal regulatory requirements on the path to approval and distribution can be daunting – and time consuming, at a time when speed to market is of the essence. The Cardinal Health title model program means that we take on ownership of your product and financial risk on the back-end, so you can stay focused on getting your product to market — not on collections and returns. While initially conceived as a solution for companies coming to market for the first-time, several customers have adopted title model as their long-term solution, and others well into their lifecycle are evaluating title model as an option to ease their A/P burden and for its financial benefits to their business.
As an integrated offer that combines the expertise of Cardinal Health Specialty Solutions’ Regulatory Sciences and 3PL, the Title Model Program can help pharma companies obtain the necessary State Board of Pharmacy (SBOP) licenses and registrations needed to distribute products across the U.S. While our Regulatory Sciences team obtains licenses, the 3PL Services team empowers you to launch your product into the market right away through the title model program. A recent case study demonstrates how we can help you maintain your market momentum and competitive edge and avoid costly delays. For the start-up company featured in this case, their product was distributed five months faster than would have been possible had they waited for state licensing approval, and they reduced their distribution costs by 16% -- compelling results and savings.
Read the Case Study >>